Oertel WH - Search Results

1

Pain in Parkinson's Disease: Current Concepts and a New Diagnostic Algorithm.

Mylius V, Ciampi de Andrade D, Cury RG, Teepker M, Ehrt U, Eggert KM, Beer S, Kesselring J, Stamelou M, Oertel WH, Möller JC, Lefaucheur JP. Mylius V, et al. Among authors: oertel wh. Mov Disord Clin Pract. 2015 Aug 9;2(4):357-364. doi: 10.1002/mdc3.12217. eCollection 2015 Dec. Mov Disord Clin Pract. 2015. PMID: 30363602 Free PMC article. Review.

2

Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro.

Eggert K, Schlegel J, Oertel W, Würz C, Krieg JC, Vedder H. Eggert K, et al. Neurosci Lett. 1999 Jul 16;269(3):178-82. doi: 10.1016/s0304-3940(99)00443-7. Neurosci Lett. 1999. PMID: 10454161

3

Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: a pilot study.

Möller JC, Stiasny K, Hargutt V, Cassel W, Tietze H, Peter JH, Krüger HP, Oertel WH. Möller JC, et al. Among authors: oertel wh. Mov Disord. 2002 May;17(3):474-81. doi: 10.1002/mds.10020. Mov Disord. 2002. PMID: 12112193

4

Myoclonic encephalopathy caused by chronic bismuth abuse.

Teepker M, Hamer HM, Knake S, Bandmann O, Oertel WH, Rosenow F. Teepker M, et al. Among authors: oertel wh. Epileptic Disord. 2002 Dec;4(4):229-33. Epileptic Disord. 2002. PMID: 12600808 Free article.

5

Role of dopamine transporter SPECT for the practitioner and the general neurologist.

Oertel WH, Gerstner A, Höffken H, Dodel RC, Eggert KM, Möller JC. Oertel WH, et al. Mov Disord. 2003 Oct;18 Suppl 7:S9-15. doi: 10.1002/mds.10572. Mov Disord. 2003. PMID: 14531040

6

Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: a decision-analytic approach.

Dodel RC, Höffken H, Möller JC, Bornschein B, Klockgether T, Behr T, Oertel WH, Siebert U. Dodel RC, et al. Among authors: oertel wh. Mov Disord. 2003 Oct;18 Suppl 7:S52-62. doi: 10.1002/mds.10580. Mov Disord. 2003. PMID: 14531047

7

Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients.

Stiasny-Kolster K, Möller JC, Zschocke J, Bandmann O, Cassel W, Oertel WH, Hoffmann GF. Stiasny-Kolster K, et al. Among authors: oertel wh. Mov Disord. 2004 Feb;19(2):192-6. doi: 10.1002/mds.10631. Mov Disord. 2004. PMID: 14978675

8

Lack of association between the interleukin-1 alpha (-889) polymorphism and early-onset Parkinson's disease.

Möller JC, Depboylu C, Kölsch H, Lohmüller F, Bandmann O, Gocke P, Du Y, Paus S, Wüllner U, Gasser T, Oertel WH, Klockgether T, Dodel RC. Möller JC, et al. Among authors: oertel wh. Neurosci Lett. 2004 Apr 15;359(3):195-7. doi: 10.1016/j.neulet.2004.01.058. Neurosci Lett. 2004. PMID: 15050696 Clinical Trial.

9

Predictors of sudden onset of sleep in Parkinson's disease.

Körner Y, Meindorfner C, Möller JC, Stiasny-Kolster K, Haja D, Cassel W, Oertel WH, Krüger HP. Körner Y, et al. Among authors: oertel wh. Mov Disord. 2004 Nov;19(11):1298-305. doi: 10.1002/mds.20163. Mov Disord. 2004. PMID: 15389999

10

Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study.

Stiasny-Kolster K, Kohnen R, Schollmayer E, Möller JC, Oertel WH; Rotigotine Sp 666 Study Group. Stiasny-Kolster K, et al. Among authors: oertel wh. Mov Disord. 2004 Dec;19(12):1432-8. doi: 10.1002/mds.20251. Mov Disord. 2004. PMID: 15390055 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

641 results

Search Page